Gormonal'naya terapiya v klimakterii: rekomendatsii dlya klinicheskoy praktiki

Cite item

Full Text


About the authors

Ya Z Zaydieva


  1. Pines A, Sturdee DW, Birkhauser MH. IMS Updated Recommendations on postmenopausal hormone therapy. Climacteric 2007; 10: 195-6.
  2. Балан В.Е. Урогенитальные расстройства. В кн.: Руководство по климактерию. Под ред. В.П.Сметник, В.И.Кулакова. М., 2001; с. 194-256.
  3. MacLennan A, Lester S, Moore V. Oral estrogen replacement therapy versus placebo for hot flushes: a systemic review. Climacteric 2001; 4: 58-74.
  4. Delmas PD, Rizzoli R, Cooper C, Reginster JY. Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation. Osteoporos Int 2005; 16: 1-5.
  5. Rosano GMC, Mercuro G, Vitale C et al. How progestins influence the cardiovascular effect of hormone replacement therapy. Gynecol Endocrinol 2001; 15: 9-17.
  6. van de Weijer PH, Mattsson LA, Ylikorkala O. Benefits and risks of long-term low-dose oral continuous combined hormone therapy. Maturitas 2007; 56 (3): 231-48.
  7. Sitruk-Ware R, Husmann F, Thijssen JHH et al. Role of progestin with partial antiandrogenic effects. Climacteric 2004; 7: 238-54.
  8. Lethaby A, Suckling J, Barlow DH et al. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding. Cochrane Database Syst Rev 2004; 3: CD000402.
  9. Goeretzleher G. The role of progestogens in hormone replacement. Drugs of Today 2001; 37 (Suppl. G): 1-8.
  10. Riphagen FE. Intrauterine application of progestins in hormone replacement therapy: a review. Climacteric 2000; 3: 199-211.
  11. Genazzani AR, Gambacciani M, Simoncini T. Menopause and aging, quality of life and sexuality. IMS Statement following 6th IMS Workshop, Pisa, December 2006. Climacteric 2007; 10: 88-96.
  12. Newhouse IJ, Clement DB, Lai C. Med Sci Sport Exerc 1993; 25 (5): 562-71.
  13. Сметник В.П., Бутарева Л.Б. Место Магне В6 в коррекции психовегетативных расстройств у женщин с климактерическим синдромом в постменопаузе. Фарматека. 2004; 15 (92): 74-8.
  14. Hays J, Ockene J.K, Brunner RL et al. Nengl J Med 2003; 348: 1839-54.
  15. Torgerson DJ, Bell-Syer SE. Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials. J Am Med Assoc 2001; 285: 2891-7.
  16. Sitruk-Ware R. Progestogens in hormonal replacement therapy: new molecules, risk, and benefits. Menоpause 2002; 9: 6-15.

Copyright (c) 2011 Zaydieva Y.Z.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies